Streetbeat News

Products Services

SCLX

Scilex Holding Company (SCLX) has responded to Health Canada's questions regarding the product composition of ELYXYB, an FDA-approved oral solution for acute migraine treatment. ELYXYB is under review by Health Canada for approval, with a decision expected in approximately 12 months. The drug is noted for its fast action and potential for low gastrointestinal side effects compared to other NSAIDs. The Canadian migraine therapeutics market is estimated to reach $400 million by 2025.

Portfolio Pulse from Happy Mohamed

March 18, 2024 | 1:04 pm

DASH

SBH

DoorDash (NASDAQ:DASH) announced new partnerships with Sally Beauty and M·A·C Cosmetics, expanding its on-demand beauty selection. This includes over 150K non-restaurant stores across North America. The partnerships aim to deliver beauty, hair, makeup, and nail essentials in under an hour. Sally Beauty offers a $0 delivery fee through May 31, 2024, on DoorDash. M·A·C Cosmetics will provide on-demand makeup and skincare products. The expansion also builds on DoorDash's existing partnership with Sephora, offering Beauty Insider members access to exclusive sales events. DoorDash's beauty category has grown significantly since its 2021 launch, now featuring over 400K beauty and personal care products.

Portfolio Pulse from Happy Mohamed

March 18, 2024 | 1:02 pm

AIRG

Airgain has entered into a global distribution agreement with Techship for the NimbeLink family of plug-in cellular modems. This partnership aims to support OEMs in designing and producing connected devices by providing global distribution of Airgain's cellular modems.

Portfolio Pulse from Benzinga Newsdesk

March 18, 2024 | 1:01 pm

AZN

GRAIL, LLC announced a novel risk classification test on its Methylation Platform for lung cancer study, in collaboration with AstraZeneca (NASDAQ:AZN). This test, validated for Stage I lung adenocarcinoma, supports tissue-free, blood-based cancer detection and aims to aid in clinical trial selection and precision oncology. The collaboration with AstraZeneca, initiated in 2022, focuses on developing companion diagnostic assays for AstraZeneca's therapies.

Portfolio Pulse from Happy Mohamed

March 18, 2024 | 1:01 pm

AAPL

GOOG

Alphabet Inc's (NASDAQ:GOOG) shares rose following reports of discussions with Apple Inc (NASDAQ:AAPL) to integrate Google's Gemini AI into iPhones. The negotiations focus on licensing Gemini for new iPhone features. Apple, also in talks with OpenAI, has lagged in AI development compared to peers. Both companies' stocks traded higher after the news, with Alphabet's shares up 4.85% to $149.06.

Portfolio Pulse from Adam Eckert

March 18, 2024 | 12:57 pm

EH

NVEI

TSVT

Nuvei's shares surged 33% amid reports of buyout talks with Advent International. 2seventy Bio's stock jumped 50% following an FDA Advisory Committee's favorable vote on Abecma for multiple myeloma. EHang's shares increased 17% as the company started selling its EH216-S flying taxi on Taobao.

Portfolio Pulse from ryanfaloona@benzinga.com

March 18, 2024 | 12:44 pm

VERB

Verb Technology Company, Inc. (NASDAQ:VERB) shares surged 16% in premarket trading, following the announcement of its Market.live platform's integration with Facebook and Instagram for social shopping, and the addition of 100 retail brands to its livestream social shopping platform.

Portfolio Pulse from Lekha Gupta

March 18, 2024 | 12:42 pm

MBLY

Mobileye announced it will wind down its aftermarket solutions unit, stating this move will not materially impact its 2024 financial results.

Portfolio Pulse from Benzinga Newsdesk

March 18, 2024 | 12:40 pm

CTXR

Citius Pharmaceuticals announced that the FDA has accepted the BLA resubmission for LYMPHIR, a treatment for adults with relapsed or refractory cutaneous T-cell lymphoma. The FDA has set a PDUFA target action date of August 13, 2024.

Portfolio Pulse from Benzinga Newsdesk

March 18, 2024 | 12:37 pm

HSAI

Hesai Technology (NASDAQ:HSAI) and Leapmotor announced a strategic partnership to enhance intelligent driving experiences using Hesai's automotive lidar products. This collaboration, building on their partnership since 2021, involves equipping Leapmotor's vehicles with Hesai's AT128 lidar, including the new C10 EV. Leapmotor's recent joint venture with Stellantis Group aims to boost global sales of its products, with Hesai playing a key role in supplying advanced intelligent driving systems. Hesai is expanding its lidar product portfolio to meet diverse market needs, indicating a growing demand for lidar-equipped intelligent driving solutions.

Portfolio Pulse from Happy Mohamed

March 18, 2024 | 12:37 pm